Paras Healthcare, a leading multi-specialty hospital chain, has revived its long-pending initial public offering (IPO) plans with an estimated target of raising around $200 million (approximately ₹1,650 crore). The move comes amid strong sector tailwinds, rising investor interest in organized healthcare, and the group’s ambitious growth agenda to add beds, upgrade facilities, and strengthen its presence in tier-2 and tier-3 cities across North and East India.
Glimpse:
The revived IPO, expected to be a mix of fresh issue and offer for sale, will fund new hospital developments (adding 1,000+ beds), technology upgrades (AI diagnostics, robotic surgery, digital health platforms), debt reduction, and potential acquisitions. Paras operates 6 hospitals with over 2,000 beds and strong performance in oncology, cardiology, neurosciences, and orthopaedics. The listing aims to capitalize on India’s growing private healthcare market, improve liquidity for existing investors, and accelerate Paras’ goal of becoming one of the top organized hospital chains in the country.
Paras Healthcare, one of India’s prominent multi-specialty hospital operators with a strong presence in tier-2 and tier-3 cities, has officially revived its initial public offering (IPO) plans after a multi-year pause. The company, which had previously filed draft papers with SEBI in 2021 but deferred the listing due to market conditions, is now targeting a raise of approximately $200 million (around ₹1,650 crore) in what could become one of the largest healthcare IPOs in recent years. The announcement, confirmed through regulatory updates and market sources on February 27, 2026, reflects renewed investor confidence in the sector amid strong post-pandemic recovery, increasing insurance penetration, and growing demand for quality tertiary care outside major metros.
The proposed IPO is expected to include a fresh issue to fund growth initiatives and an offer for sale by existing shareholders, including promoters and select investors. Proceeds from the fresh issue will primarily support Paras’ aggressive expansion plans, including the addition of over 1,000 new beds through greenfield hospitals and brownfield upgrades in high-growth markets across North and East India. Funds will also be allocated to technology enhancements (AI-powered diagnostics, robotic surgery systems, telemedicine integration), debt reduction to strengthen the balance sheet, and potential strategic acquisitions to deepen specialty capabilities in oncology, cardiology, neurosciences, and organ transplantation.
Paras Healthcare currently operates six multi-specialty hospitals with a combined capacity exceeding 2,000 beds, known for high clinical standards, patient-centric care, and strong performance in complex procedures. The group has consistently reported robust occupancy, healthy EBITDA margins, and steady revenue growth, driven by medical tourism inflows, high-acuity case volumes, and a trusted brand in underserved regions. The IPO comes at an opportune time when India’s private hospital sector is attracting significant investor interest due to structural tailwinds such as an aging population, rising chronic disease burden, and government initiatives promoting healthcare access and insurance coverage.
Market analysts anticipate strong demand from institutional investors both domestic and foreign given Paras’ proven track record, scalable model, and attractive valuation potential compared to listed peers. The company has engaged top-tier merchant bankers and is in the process of updating its draft red herring prospectus (DRHP) to reflect current financials and market conditions. If successful, the listing would provide liquidity to early investors, enhance brand visibility, and inject substantial capital to fuel Paras’ ambition of becoming one of India’s leading organized healthcare chains.
This revival underscores the sector’s maturation and growing public market appeal, where large hospital groups are increasingly turning to IPOs to fund expansion, technology adoption, and consolidation in a highly fragmented market. Paras’ move is widely seen as a bellwether that could encourage other prominent chains to pursue listings in the near future.
“Our IPO is a natural next step in Paras’ journey unlocking capital to build more hospitals, embrace cutting-edge technology, and bring world-class care to millions more Indians in the cities and towns we serve.”
By
HB Team
Related News
